skip to main content
Show Results with:

The relationship between baseline risk and mortality in ST-elevation acute myocardial infarction treated with pharmacological reperfusion: Insights from the Global Utilization of Strategies To open Occluded arteries (GUSTO) V trial

Brener, S. J. et al.

American heart journal. VOL 150; NUMBER 1, ; 2005, 89-93 -- Elsevier Science B.V., Amsterdam (pages 89-93) -- 2005

Online access

  • Title:
    The relationship between baseline risk and mortality in ST-elevation acute myocardial infarction treated with pharmacological reperfusion: Insights from the Global Utilization of Strategies To open Occluded arteries (GUSTO) V trial
  • Author: Brener, S. J.;
    Lincoff, A. M.;
    Bates, E. R.;
    Jia, G.;
    Armstrong, P. W.;
    Guetta, V.;
    Hochman, J. S.;
    Savonitto, S.;
    Wilcox, R. G.;
    White, H. D.
  • Found In: American heart journal. VOL 150; NUMBER 1, ; 2005, 89-93
  • Journal Title: American heart journal.
  • Subjects: Medicine; Biotechnology; Pharmaceutical Chemistry; LCC: RC681; Dewey: 616.12
  • Publication Details: Elsevier Science B.V., Amsterdam
  • Language: English
  • Abstract: BackgroundWe studied the potential interaction between baseline risk of death and treatment with either standard fibrinolytic monotherapy or combination fibrin and platelet lysis with respect to outcome of patients with ST-elevation myocardial infarction (STEMI) enrolled in the Global Utilization of Strategies To open Occluded arteries (GUSTO) V trial.MethodsUsing the Thrombolysis in Myocardial Infarction (TIMI) risk score (0-14 points) for STEMI, we analyzed the 30-day and 1-year mortality according to treatment assignment and risk category. Multivariable analysis was performed to identify the potential interactions between treatment and baseline risk.ResultsThe TIMI risk score could be calculated in 16256 patients (98% of patients enrolled). The median score was 2 (1-4) in each treatment group (P = .07). The risk score was significantly associated with 30-day mortality (hazard ratio [HR], 1.52; 95% CI 1.47-1.56, P P P P = .29).ConclusionThe TIMI risk score accurately predicted early and 1-year mortality in patients with STEMI treated with pharmacological reperfusion. We did not identify any heterogeneity in the response of patients to combination therapy according to their TIMI risk score.
  • Identifier: Journal ISSN: 0002-8703
  • Publication Date: 2005
  • Physical Description: Electronic
  • Accrual Information: Monthly
  • Shelfmark(s): 0817.000000
  • UIN: ETOCRN172376507

Searching Remote Databases, Please Wait